| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
RDNT sits in the Life Sciences Tools & Services industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 1.21M | $76.88M | - | |
| CEO | 507.2K | $29.73M | - | |
| COO | 261.2K | - | - | |
| VP | 200.2K | - | - | |
| Dir | 177.0K | $9.54M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 22, 2015 | Hames Norman R56 | Executive Vice President | Sell | 5,000 | $6.83 | $34,150.00 | -0.7% | |
| May 20, 2015 | Stolper Mark | Executive VP And CFO | Sell | 50,000 | $6.86 | $343,000.00 | -20.9% | |
| Mar 20, 2015 | Hames Norman R56 | Executive Vice President | Sell | 11,390 | $7.60 | $86,564.00 | -1.6% | |
| Mar 19, 2015 | Hames Norman R56 | Executive Vice President | Sell | 35,000 | $7.79 | $272,750.00 | -4.6% |